What Is the AFP MoM Normal Range in Pregnancy?

In most screening programs, a second-trimester maternal serum alpha-fetoprotein (AFP) result between about 0.5 and 2.5 multiples of the median (MoM) is considered normal for a singleton pregnancy. Values at or above 2.5 MoM are flagged as elevated and prompt further evaluation, while values well below 0.5 MoM can also be clinically meaningful. That said, a single number on a lab report tells you far less than you might think, because the MoM calculation itself depends on gestational age, your weight, whether you are carrying more than one baby, and several other personal factors that the laboratory adjusts for before handing you a result.

What a MoM Value Actually Represents

AFP is a protein produced first by the yolk sac and then by the fetal liver. It crosses into maternal blood in small but measurable amounts, and those amounts rise steadily as the pregnancy progresses. A raw AFP concentration in international units per milliliter doesn’t mean much on its own, because what counts as “normal” at 15 weeks is very different from what’s normal at 18 weeks. The MoM system solves this by comparing your result to the median value expected for your exact gestational week. A MoM of 1.0 means you are right at the middle of the bell curve; a MoM of 2.0 means your level is twice the expected median.

Laboratories derive their own median curves from local population data, and those curves can differ by geography and by the specific assay kit used. Research has shown that differences between assay methods shift the tails of the MoM distribution unevenly, meaning that the same fixed MoM cutoff can produce different sensitivity and specificity combinations depending on which assay a lab runs.¹ This is why your provider’s lab recalculates medians regularly and why results from different hospitals aren’t directly interchangeable.

The 0.5 to 2.5 MoM Window

The cutoff of 2.5 MoM is the most widely used threshold for calling a result “elevated.” In a large Taiwanese study of over 46,000 screened singleton pregnancies, women with AFP values of 0.5 to 2.49 MoM were classified as the normal group, while those at 2.5 MoM or above were flagged for further workup.² Some programs use a slightly lower cutoff of 2.0 MoM when screening for neural tube defects specifically, which catches more true positives but also raises the false-positive rate. The 2.5 MoM threshold strikes a balance that most clinicians and screening guidelines have settled on.

On the low end, there is no universally agreed-upon cutoff for “too low.” A value below 0.5 MoM can contribute to a higher risk calculation for chromosomal conditions when AFP is used as part of a multi-marker panel (the quad screen), but low AFP alone is rarely acted upon in isolation. The clinical energy around AFP screening overwhelmingly focuses on elevations.

Adjustments That Change Your MoM

Before a lab reports your MoM value, it adjusts the raw number for several factors known to shift AFP levels independently of any fetal problem. In one large study, AFP MoM values were corrected for gestational age, maternal weight, race or ethnicity, smoking status, and pre-existing diabetes before being reported.³ Each of these matters for a straightforward reason: they all change how much AFP ends up in your blood without implying anything is wrong with the pregnancy.

Weight is one of the biggest confounders. Heavier women have a larger blood volume, which dilutes the AFP concentration and can make a genuinely normal pregnancy look artificially low. Research comparing weight-correction methods found that the mean difference in AFP MoM values between two standard correction approaches was about 8%, enough to push a borderline result from one side of the cutoff to the other.⁴ If a lab does not know your accurate weight at the time of the blood draw, or uses a less precise correction formula, the final MoM may be slightly off.

Gestational dating errors are another common reason for a result that looks abnormal but isn’t. Because AFP rises steadily through the second trimester, even a one-week discrepancy between the dating used by the lab and the actual gestational age can meaningfully shift the MoM. This is why an ultrasound to confirm dates is often the first step after an unexpected result.

What an Elevated AFP Can Signal

When AFP comes back at 2.5 MoM or above, the list of possible explanations ranges from benign to serious. The classic association is with open neural tube defects like spina bifida and anencephaly. In a study of 905 pregnancies referred for elevated AFP, ultrasound correctly identified 49 of 50 neural tube defects, giving it a sensitivity of 98% and a specificity of 100% for those conditions.⁵ That’s remarkably accurate, and it’s the main reason a detailed anatomy ultrasound is the standard next step when AFP is high.

Abdominal wall defects also drive AFP levels up, sometimes dramatically. Pregnancies with gastroschisis (where the intestines protrude through an opening beside the navel) have shown median AFP values around 9.4 MoM, while omphalocele (a defect where organs push through the navel itself) runs closer to 4.2 MoM.⁶ These numbers are well above the 2.5 MoM screening threshold, so abdominal wall defects tend to generate very high AFP readings rather than borderline ones.

Less commonly, a markedly elevated AFP during pregnancy has been traced to a maternal ovarian tumor that secretes AFP on its own, sometimes identified when an ultrasound to investigate the high AFP also reveals an adnexal mass.⁷ This is rare, but it illustrates why providers don’t assume every high AFP is a fetal problem.

Twin Pregnancies and the MoM Shift

If you’re carrying twins, your AFP will be significantly higher than a singleton median simply because two fetuses are producing the protein. Research has found AFP levels roughly two-fold higher in twin pregnancies compared with singletons at the same gestational age.⁸ This means a twin pregnancy that scores 2.0 MoM on a singleton scale is entirely normal, not borderline elevated.

Screening programs handle this by using twin-specific medians so that the MoM calculation reflects two babies from the start. Within twin pregnancies, some variation exists depending on whether the twins share a placenta. One study found that the median AFP for twin pregnancies overall was about 1.9 MoM relative to singleton norms, but monozygotic twins (who more often share a placenta) tended to run higher than dizygotic twins.⁹ In twin pregnancies where AFP climbs above 4.5 MoM on a singleton scale, outcomes can be worse: one study of twins found that those with monochorionic placentation and AFP above 4.5 MoM had a fetal survival rate of 67%, compared with 96% for twins at the same placental type with normal AFP levels.¹⁰

When the AFP Is High but No Structural Problem Is Found

Here is where things get more nuanced. In the majority of cases where AFP comes back elevated and a detailed ultrasound looks completely normal, the pregnancy goes on to be healthy. But “unexplained” elevations are not entirely benign from a statistical standpoint. Multiple studies have linked second-trimester AFP above 2.5 MoM, even without an identifiable cause, to higher rates of complications later in pregnancy.

One study observed that among women with AFP at 2.5 MoM or above, about 24% delivered preterm, compared with roughly 4% of women at the low end of the normal range, an odds ratio of nearly 9.¹¹ Similar gradients showed up for preeclampsia and placental abnormalities in the same analysis. Another study found that unexplained elevated AFP was associated with increased rates of preterm delivery, premature rupture of membranes, restricted fetal growth, and lower birth weights.¹² A Turkish study echoed these findings, connecting high AFP MoM values in the second trimester with preeclampsia, growth restriction, premature rupture of membranes, and fetal death.¹³

The working theory is that a high AFP with a normal-looking baby on ultrasound may reflect subtle placental dysfunction. AFP gets into maternal blood through the placental barrier, so anything that makes that barrier leakier, such as poor placental development, can allow more AFP through. That same placental weakness may later manifest as preeclampsia or growth restriction. Providers who see an unexplained elevation often schedule more frequent growth scans and blood pressure checks in the third trimester, treating the result as a flag for closer monitoring rather than a diagnosis.

What Happens After an Abnormal Result

If your AFP comes back elevated, the first step is almost always a detailed ultrasound. Modern high-resolution ultrasound has largely replaced AFP as the primary detection method for neural tube defects, and many clinicians now view the blood test as a complement to imaging rather than the other way around.¹⁴ The ultrasound can confirm or rule out structural defects, verify the number of fetuses, and correct any dating error that may have skewed the MoM calculation.

If the ultrasound raises suspicion of a neural tube defect but isn’t conclusive, an amniocentesis may be offered. The amniotic fluid can be tested for AFP directly (amniotic fluid AFP tends to be much higher than blood levels when a defect is present) and for an enzyme called acetylcholinesterase, which leaks into the fluid when the neural tube is open. Combining amniotic fluid AFP with an acetylcholinesterase assay pushes the screening accuracy for neural tube defects to over 99%.¹⁵ Elevated acetylcholinesterase in amniotic fluid was found to be significantly associated with open neural tube defects in one of the earliest studies to validate the approach.¹⁶

For most women, the ultrasound will look entirely normal, and the elevated AFP becomes one of those “unexplained” results discussed earlier. In that situation, no further invasive testing is needed, but the information still has value for guiding the level of surveillance in the rest of the pregnancy.

The Emotional Weight of a False Alarm

Something the clinical literature takes seriously but patients are rarely warned about is the anxiety that accompanies a flagged result. Because only a small fraction of elevated AFP results turn out to reflect a true problem, the majority of women who get the call that their AFP is high will ultimately be told everything is fine. But the period between learning the result and getting that reassurance can be genuinely distressing.

In one study, women with elevated AFP and their partners showed significantly heightened anxiety after being notified, and that anxiety persisted until further testing produced normal results. Counseling before definitive testing did not reduce the anxiety.¹⁷ A separate study found that 65% of women in the false-positive group felt the test caused anxiety, compared with 17% of women whose initial result was normal.¹⁸ The reassuring finding from the first study is that once the follow-up ultrasound or amniocentesis confirmed a healthy pregnancy, anxiety dropped back to baseline and did not linger for the rest of the pregnancy. Still, knowing in advance that a borderline result is common and usually benign can help prepare you for that waiting period.

AFP Screening in the Age of Cell-Free DNA

Over the past decade, cell-free DNA (cfDNA) testing, often marketed as non-invasive prenatal testing, has reshaped prenatal screening. These blood tests analyze tiny fragments of fetal DNA circulating in the mother’s blood and are highly accurate for detecting chromosomal conditions like Down syndrome. Many providers and patients have shifted toward cfDNA as a first-line screen, sometimes skipping the traditional quad screen that includes AFP altogether.

This trend has raised concerns among maternal-fetal medicine specialists. A review of the issue noted that while cfDNA excels at chromosomal screening, it does not measure AFP and therefore cannot flag neural tube defects or the placental problems associated with unexplained AFP elevations.¹⁹ If a woman opts for cfDNA alone and her provider does not separately order an AFP level or ensure a detailed anatomy ultrasound, she may miss the information that AFP screening provides. Some practices now offer a standalone AFP blood draw alongside cfDNA, precisely to fill this gap. If you are deciding between screening options, it’s worth asking whether AFP will still be measured.

Why Different Labs May Give You Different Numbers

One frustration patients encounter is that the same blood sample can theoretically produce slightly different MoM values depending on which lab processes it. The MoM system was designed to level the playing field across different assay platforms and population medians, but it doesn’t do so perfectly. Research comparing laboratories found that differences in assay methodology affect the tails of the MoM distribution more than the center, meaning results near the 2.5 MoM cutoff are most vulnerable to inter-lab variability.¹ Population-specific median equations also differ geographically: a study comparing Belgian population medians with those from a UK-based screening program found that adopting another country’s median equations shifted the resulting MoM distributions.²⁰

For you as a patient, the practical takeaway is that a MoM of 2.4 at one lab and 2.6 at another may reflect lab-to-lab differences more than any real change in your pregnancy. Borderline results deserve a conversation about context rather than automatic escalation. Your provider should factor in the ultrasound findings, your clinical picture, and the lab’s own performance data before deciding on next steps.

Amniotic Fluid AFP Versus Blood AFP

When an amniocentesis is performed after an elevated blood result, the AFP measured in the amniotic fluid operates on an entirely different scale. Amniotic fluid AFP concentrations in pregnancies with abdominal wall defects illustrate the difference: omphalocele showed a mean amniotic fluid AFP of about 3.7 MoM, gastroschisis around 23 MoM, and a rarer combined defect type averaged 44 MoM.²¹ These numbers are far higher than what you would see in maternal serum even with the same conditions, because the protein concentration in the fluid surrounding the baby is much greater than what filters into your bloodstream. The amniotic fluid AFP result is interpreted using its own set of medians and cutoffs, so if you see an amniotic fluid report, don’t compare those numbers to the serum ranges discussed earlier.

Amniotic fluid testing also adds the acetylcholinesterase assay, which specifically detects open neural tube defects. Using both markers together in the fluid was shown to correctly classify pregnancies with open spina bifida or anencephaly even in cases where the AFP alone was ambiguous.²² This combination is why amniocentesis, when it’s needed, remains a powerful diagnostic tool rather than just another screening step.